LeapFinancial | $3,500,000 | (Dec 20, 2024)
TG0 | $5,619,170 | (Dec 20, 2024)
Mindgard | $8,000,000 | (Dec 20, 2024)
Certified by Founder
Lodge
Congruence Therapeutics
start up
Canada
- Montreal, Quebec
- 07/03/2023
- Series A
- $65,000,000
Congruence Therapeutics is a drug discovery company that is uniquely harnessing the power of innovative fields such as protein dynamics, biophysics, machine learning and computational chemistry. Our ground-breaking discovery engine, Revenir, sees proteins in ways others have been unable to see - in their full dynamic state.
- Industry Biotechnology Research
- Website https://congruencetx.com/
- LinkedIn https://www.linkedin.com/company/congruencetx/people/
Related People
Clarissa DesjardinsFounder
Canada -
Montreal, Quebec,
Experienced biotechnology executive and founder of three successful biotechnology companies. Founded Clementia Pharmaceuticals and led it to Phase 3 human clinical trials for fibrodysplasia ossificans progressiva (FOP), a disease of abnormal new bone formation, until its acquisition by Ipsen for $1.3 billion dollars in 2019.
ŌURA | $200,000,000 | (Dec 20, 2024)
Buildpeer | $2,500,000 | (Dec 20, 2024)
Embeddable | $6,238,050 | (Dec 20, 2024)
Tenor | $5,400,000 | (Dec 20, 2024)
SOTELIX Endoscopy | $1,700,000 | (Dec 20, 2024)
Double(US) | $3,900,000 | (Dec 20, 2024)
Hauler Hero | $10,000,000 | (Dec 20, 2024)
TripSuite | $5,000,000 | (Dec 20, 2024)
Seekho | $8,000,000 | (Dec 19, 2024)